0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 21685 results.
The global Nilotinib market size was valued at US$ 1881.2 million in 2023. With growing demand in downstream market, the Nilotinib is forecast to a...
Catalog:
LPI
March 2024
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the 3rd Generation EGFR market will undergo major changes...
Catalog:
Arsta
May 2023
Price: USD 3,600.00
Anlotinib is a new, orally administered tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (VEGFR), fibroblast growth...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). The global Nilotinib market was valued at US$ 1923 million in...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Tyrosine is a popular dietary supplement used to improve alertness, attention and focus. It produces important brain chemicals that help nerve cells...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Tyrosine is a popular dietary supplement used to improve alertness, attention and focus. It produces important brain chemicals that help nerve cells...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR) is a tyrosine kinase signaling pathway that has a fundamental role in many...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK)...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Exeter Erlotinib Hydrochloride Tablet market size was valued at US$ million in 2023. With growing demand in downstream market, the Exeter...
Catalog:
LPI
February 2024
Price: USD 3,660.00
